Stop by booth 641 to meet your next viral vector partner.

Founded in 2014, Genezen is a viral vector CDMO focused on supporting the demands of the cell and gene therapy manufacturing market worldwide — making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers the following capabilities, building on the company's expansive knowledge and experience. 

  • Process Development
  • Analytical Development
  • cGMP Viral Vector Manufacturing
  • Patient Sample Testing
  • Cell Therapy Manufacturing
  • Master Cell Bank Production and Expansion